Search research articles
Contact Us
Filters
Showing results (201-210 of 235) with videos related to
Page
of 24
Sort By:
Nuclear Medicine and Biology
|
June 1, 2000
High specific radioactivity (1R,2S)-4-[(18)F]fluorometaraminol: a PET radiotracer for mapping sympathetic nerves of the heart
O Langer, H Valette, F Dollé, et al.
Journal of Computer Assisted Tomography
|
December 1, 1983
Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine
M Bergström, V P Collins, E Ehrin, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 1, 1990
Positron emission tomographic measurements of cerebral glucose utilization using [1-11C]D-glucose
G Blomqvist, S Stone-Elander, C Halldin, et al.
Nuclear Medicine and Biology
|
May 1, 1993
Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites--current status
V W Pike, C Halldin, C Crouzel, et al.
Psychopharmacology
|
December 1, 1996
Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907
H Hall, C Halldin, D Dijkstra, et al.
Acta Radiologica. Supplementum
|
January 1, 1986
Peripheral benzodiazepine binding sites in human gliomas evaluated with positron emission tomography
M Bergström, M Mosskin, K Ericson, et al.
Nuclear Medicine and Biology
|
October 1, 1995
[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations
C Lundkvist, C Halldin, C G Swahn, et al.
European Journal of Nuclear Medicine
|
February 1, 1994
Preparation of a potential positron emission tomographic radioligand for the dopamine transporter
L Müller, C Halldin, C Foged, et al.
Bioorganic & Medicinal Chemistry
|
April 20, 2001
Synthesis of high-specific-radioactivity 4- and 6-[18F]fluorometaraminol-PET tracers for the adrenergic nervous system of the heart
O Langer, F Dollé, H Valette, et al.
European Journal of Nuclear Medicine
|
November 5, 1997
Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomography
C Foged, C Halldin, C Loc'h, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 235) with videos related to
Sort By:
Page
of 24
Nuclear Medicine and Biology
|
June 1, 2000
High specific radioactivity (1R,2S)-4-[(18)F]fluorometaraminol: a PET radiotracer for mapping sympathetic nerves of the heart
O Langer, H Valette, F Dollé, et al.
Journal of Computer Assisted Tomography
|
December 1, 1983
Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine
M Bergström, V P Collins, E Ehrin, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 1, 1990
Positron emission tomographic measurements of cerebral glucose utilization using [1-11C]D-glucose
G Blomqvist, S Stone-Elander, C Halldin, et al.
Nuclear Medicine and Biology
|
May 1, 1993
Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites--current status
V W Pike, C Halldin, C Crouzel, et al.
Psychopharmacology
|
December 1, 1996
Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907
H Hall, C Halldin, D Dijkstra, et al.
Acta Radiologica. Supplementum
|
January 1, 1986
Peripheral benzodiazepine binding sites in human gliomas evaluated with positron emission tomography
M Bergström, M Mosskin, K Ericson, et al.
Nuclear Medicine and Biology
|
October 1, 1995
[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations
C Lundkvist, C Halldin, C G Swahn, et al.
European Journal of Nuclear Medicine
|
February 1, 1994
Preparation of a potential positron emission tomographic radioligand for the dopamine transporter
L Müller, C Halldin, C Foged, et al.
Bioorganic & Medicinal Chemistry
|
April 20, 2001
Synthesis of high-specific-radioactivity 4- and 6-[18F]fluorometaraminol-PET tracers for the adrenergic nervous system of the heart
O Langer, F Dollé, H Valette, et al.
European Journal of Nuclear Medicine
|
November 5, 1997
Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomography
C Foged, C Halldin, C Loc'h, et al.
Page
of 24